Low hemoglobin in older adults stems from a mix of overlapping causes, and in roughly a third of cases no single explanation is found even after thorough testing. The most common identifiable drivers include iron deficiency from slow gastrointestinal bleeding, chronic low-grade inflammation that locks iron away from red blood cell production, declining kidney function that blunts the hormonal signal for new red cells, and nutritional shortfalls in vitamins like B12 and folate. What makes anemia in the elderly especially tricky is that these causes rarely act alone, and the threshold for “low” hemoglobin is itself debated.
How Common Is It, and Where Is the Line?
Anemia affects a sizable share of people over 65, but the exact number depends on where you draw the cutoff. The World Health Organization defines anemia as hemoglobin below 12 g/dL in women and below 13 g/dL in men. Using those thresholds, population studies consistently find prevalence rates somewhere around 6 to 14 percent in community-dwelling older adults, with the numbers climbing steeply in the very old and in people living in nursing homes or assisted-care settings. One large Italian study found that mild anemia appeared in about 14 percent of elderly participants, and that shifting the cutoff even slightly, to 12.2 g/dL for women and 13.2 g/dL for men, bumped the prevalence up to nearly 17 percent.1Haematologica. Prevalence, incidence and types of mild anemia in the elderly: the “Health and Anemia” population-based study
The debate about where to set the line matters because even mildly low hemoglobin in older people carries real consequences. A primary-care study of nearly 7,000 adults aged 65 to 95 found mild anemia in about 6 percent of women and 8 percent of men, and the researchers argued that the threshold for men should actually be higher in this age group because of the way outcomes tracked with hemoglobin levels.2PubMed. Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women In other words, a hemoglobin value that looks “normal” on paper might already signal trouble in an older man.
Iron Deficiency and Hidden Gastrointestinal Bleeding
Iron deficiency is the single most common treatable cause of low hemoglobin at any age, and in older adults the culprit is often silent, chronic blood loss from the gastrointestinal tract. Small polyps, ulcers, diverticular disease, angiodysplasia, and occasionally cancers of the stomach or colon can each ooze enough blood over weeks and months to drain iron stores without producing visible symptoms. A classic New England Journal of Medicine evaluation found that gastrointestinal lesions, in both the upper tract and the colon, are frequently discovered in patients with unexplained iron-deficiency anemia.3PubMed. Evaluation of the Gastrointestinal Tract in Patients with Iron-Deficiency Anemia Among men and postmenopausal women who present with iron-deficiency anemia alongside GI bleeding, the estimated prevalence of that combination has been put at around 61 percent.4PubMed Central. Diagnosis and treatment of iron-deficiency anemia in gastrointestinal bleeding: A systematic review
This is why doctors view iron-deficiency anemia in an older person as a red flag that warrants investigation rather than just a prescription for iron tablets. Replacing the iron without looking for the source of loss can mask a condition that needs treatment in its own right, including early-stage colorectal cancer.
Chronic Inflammation and Its Quiet Effect on Red Blood Cells
Aging is accompanied by a slow, persistent rise in inflammatory signaling that researchers sometimes call “inflammaging.” You do not need a raging infection or autoimmune flare for this to matter. Conditions like obesity, heart failure, diabetes, arthritis, and even the gradual accumulation of senescent cells can keep inflammatory markers gently elevated for years. That low hum of inflammation has several downstream effects on hemoglobin. It interferes with iron availability by routing it into storage rather than into new red blood cells, dampens the kidney’s production of erythropoietin (the hormone that tells your bone marrow to make more red cells), and speeds up the destruction of circulating red blood cells through oxidative stress.5PubMed Central. Anemia and Its Connections to Inflammation in Older Adults: A Review
One study from the InCHIANTI aging cohort confirmed that elevated inflammatory markers tracked with both anemia and low iron status in older adults, though the exact signaling pathway, particularly the role of the iron-regulating hormone hepcidin, was less clear-cut than initially theorized.6PubMed Central. Proinflammatory state, hepcidin, and anemia in older persons The practical upshot: an older person can have plenty of iron in storage yet still be functionally iron-starved at the level of red blood cell production because inflammation has essentially locked the pantry door.
Declining Kidney Function
Your kidneys do more than filter waste. They also produce erythropoietin, the main hormonal signal that tells bone marrow to churn out red blood cells. Kidney function declines gradually with age, and when it drops far enough, erythropoietin output falls with it. Data from the InCHIANTI study showed that older adults with severely reduced kidney filtration had significantly lower erythropoietin levels compared with those whose kidneys were still filtering well, and that this became an important driver of anemia once filtration dropped to very low levels.7JAMA Internal Medicine. Renal Function, Erythropoietin, and Anemia of Older Persons: The InCHIANTI Study
Even among elderly patients whose anemia has no other obvious explanation, erythropoietin levels tend to be inappropriately low for the degree of anemia, suggesting that a subtle shortfall in this hormone is a bigger player than it gets credit for.8PubMed Central. Erythropoietin Levels in Elderly Patients with Anemia of Unknown Etiology You do not need to be on dialysis for this to contribute. Mild-to-moderate chronic kidney disease, common in people over 70, can quietly suppress erythropoietin enough to nudge hemoglobin downward.
Vitamin Deficiencies and Malabsorption
B12 and folate are essential raw materials for building red blood cells. When either is in short supply, the marrow produces oversized, poorly functioning cells, a pattern known as megaloblastic anemia. In older adults, low B12 is more often a problem of absorption than of diet. A condition called chronic atrophic autoimmune gastritis gradually destroys the stomach lining cells that produce both acid and intrinsic factor, the protein needed to absorb B12 from food. Without enough intrinsic factor, dietary B12 passes straight through. The same condition also impairs iron absorption by reducing stomach acid, so patients can end up deficient in both B12 and iron simultaneously.9PubMed Central. Micronutrient deficiencies in patients with chronic atrophic autoimmune gastritis: A review
Atrophic gastritis grows more common with age, and its ripple effects extend beyond B12. It has been linked to deficiencies in vitamin C, vitamin D, calcium, magnesium, and zinc, with the potential for neurological complications including dementia-like symptoms that can become permanent if left untreated.10Journal of Aging Research and Lifestyle. Atrophic Gastritis (AG) and Its Clinical Sequels Among Elderly People in Finland and Estonia Folate deficiency, while less common in countries that fortify grain products, still shows up in older adults with poor dietary variety or heavy alcohol use.
Malnutrition and the Anorexia of Aging
Beyond specific vitamin deficits, broader malnutrition plays a role that often goes underappreciated. Many older adults simply eat less. Appetite declines with age due to changes in taste and smell, slower gastric emptying, side effects of medications, depression, social isolation, and dental problems. This pattern, sometimes called the anorexia of aging, is a major contributor to undernutrition in the geriatric population.11PubMed Central. Anorexia of Aging: Risk Factors, Consequences, and Potential Treatments
When protein and calorie intake fall too low, the body ramps up inflammatory signaling, which in turn suppresses red blood cell production through the same hepcidin-mediated iron-locking mechanism described earlier. Protein-energy malnutrition leads to increased cytokine production that inhibits the activity of immune and bone marrow cells, reducing hemoglobin concentration through ineffective red cell production.12PubMed. Role of nutrition on anemia in elderly This creates a feedback loop: poor nutrition triggers inflammation, inflammation worsens anemia, anemia causes fatigue and poor appetite, and the cycle deepens.
Hormonal Shifts
Testosterone, growth hormone (through its mediator IGF-1), and thyroid hormones all stimulate red blood cell production. As levels of these hormones decline with age, the bone marrow receives weaker “go” signals. Research consistently links lower testosterone to lower hemoglobin in both older men and older women.13PubMed Central. The Role of the Multiple Hormonal Dysregulation in the Onset of “Anemia of Aging”: Focus on Testosterone, IGF-1, and Thyroid Hormones
Data from the InCHIANTI cohort put numbers to this relationship. Older men in the lowest quartile of bioavailable testosterone were roughly thirteen times more likely to have anemia compared with those in the highest quartile. For women the effect was smaller but still significant, with those in the lowest quartile facing more than three times the odds. And among people who were not anemic at baseline, those with low testosterone had about double the risk of developing anemia over the next three years.14PubMed Central. Low Testosterone Levels and the Risk of Anemia in Older Men and Women Hypothyroidism, which also becomes more common with age, contributes through a similar mechanism but is more easily correctable once identified.
Medications That Lower Hemoglobin
Older adults tend to take more medications, and some of those drugs quietly chip away at hemoglobin. Blood-pressure medications are a frequently overlooked contributor. ACE inhibitors and angiotensin receptor blockers, two of the most commonly prescribed classes for hypertension, can suppress red blood cell production. The drop is usually small, but in someone who already has marginal hemoglobin from other causes, it can push them into anemia.15PubMed Central. Antihypertensive medications and anemia Other common culprits include nonsteroidal anti-inflammatory drugs (which cause GI bleeding), proton pump inhibitors (which reduce iron and B12 absorption by cutting stomach acid), certain chemotherapy agents, and anticoagulants. A medication review is a standard part of any anemia workup in an older patient, but drug-induced anemia is still underrecognized.
Bone Marrow Disorders
The bone marrow itself ages. Stem cells become less efficient, and fat gradually replaces some of the blood-producing tissue. For most people this slow decline does not cause clinically significant anemia on its own, but it reduces the marrow’s reserve capacity, making it harder to compensate when other stressors hit. In a smaller but important group of older patients, the marrow develops a specific disorder called myelodysplastic syndrome, or MDS, in which the stem cells begin producing abnormal blood cells. MDS is overwhelmingly a disease of older adults, with a median age at diagnosis of 65 to 70.16PubMed Central. Managing myelodysplastic symptoms in elderly patients
In low-risk MDS, anemia is often the dominant problem, and patients may need regular blood transfusions or drugs that stimulate red cell production. Response to those stimulating agents depends on several factors: hemoglobin level, the patient’s baseline erythropoietin level, the number of genetic mutations driving the disease, and whether the patient is still transfusion-independent.17Blood. Evaluating Mean Corpuscular Volume As Predictor for Erythropoiesis Stimulating Agent Response in Elderly Patients Diagnosed with Myelodysplasia MDS should be on the radar whenever an older person has persistent, unexplained anemia that does not respond to iron or vitamin replacement.
Telling the Causes Apart
One of the hardest diagnostic puzzles in geriatric medicine is distinguishing iron-deficiency anemia from anemia driven by chronic inflammation. Both can coexist in the same patient. The standard blood test, ferritin, is excellent at spotting iron deficiency in otherwise healthy people, but ferritin is also an inflammation marker that rises when inflammation is present, masking an underlying iron deficit. In other words, a “normal” ferritin in an older person with arthritis or heart failure might actually be hiding true iron depletion.
This is where a test called soluble transferrin receptor becomes useful. Unlike ferritin, it stays relatively unaffected by inflammation and reflects what the bone marrow is actually experiencing in terms of iron supply. A prospective multicenter study found that combining ferritin with soluble transferrin receptor and a calculated index from the two more than doubled the detection rate of iron deficiency compared with ferritin alone, jumping from about 41 percent to 92 percent.18PubMed. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index The finding has been supported by additional studies in specific disease populations, including rheumatoid arthritis patients, where the transferrin receptor test outperformed standard iron panels in sensitivity.19PubMed Central. Usefulness of Soluble Transferrin Receptor in the Diagnosis of Iron Deficiency Anemia in Rheumatoid Arthritis Patients in Clinical Practice Getting the diagnosis right matters because the treatments diverge: iron replacement for true deficiency, management of the underlying disease for inflammation-driven anemia.
Racial and Ethnic Differences in Normal Hemoglobin
What counts as “normal” hemoglobin varies by population. Black adults tend to have hemoglobin levels about 1 g/dL lower than white adults of the same age and sex, and roughly a third of that gap appears to be explained by a common gene variant, the alpha-thalassemia deletion, which is far more prevalent in people of African ancestry.20Mayo Clinic Proceedings. Anemia in the Elderly: How Should We Define It, When Does It Matter, and What Can Be Done? The clinical consequence is that applying a single universal hemoglobin cutoff may over-diagnose anemia in some groups and under-diagnose it in others.
Data from the large NHANES III follow-up underscore the point. Among non-Hispanic white participants, the hemoglobin level below which mortality risk climbed significantly was actually slightly above the WHO anemia cutoff. For non-Hispanic Black participants, the mortality-risk threshold was well below the WHO cutoff.21PubMed Central. Hemoglobin Concentration and the Risk of Death in Older Adults: Differences by Race/Ethnicity in the NHANES III Follow-up This does not mean anemia is harmless in Black older adults; it means the number at which it starts causing harm is likely different, and a one-size-fits-all definition can mislead.
Why Even Mild Anemia Matters in Older Adults
Low hemoglobin in younger people is often an inconvenience that produces fatigue. In older adults, even mildly low levels carry a different weight. Reduced oxygen delivery to muscles and the brain accelerates the functional decline that already accompanies aging, and the downstream effects can be severe.
Frailty is one of the best-studied connections. In a community-based study, anemia independently predicted frailty after controlling for age, sex, and other health conditions, roughly doubling the odds.22The Journal of nutrition, health and aging. Prevalence of Anemia and Its Association with Frailty, Physical Function and Cognition in Community-Dwelling Older Adults: Findings from the HOPE Study A three-year European trial of generally healthy, active adults over 70 found that even among people who were still robust at baseline, each decrease in hemoglobin was associated with higher odds of progressing into pre-frailty, and those who met the criteria for anemia had about 39 percent higher odds of becoming pre-frail.23PubMed Central. Hemoglobin levels and frailty status in generally healthy and active community-dwelling adults age 70 years and older in the three-year DO-HEALTH study The relationship likely runs in both directions: anemia contributes to weakness and functional decline, but the same biological processes driving frailty, particularly chronic inflammation, also suppress red blood cell production.24PubMed Central. Anemia in frailty
Anemia is also linked to reduced muscle strength and gait instability. People with low hemoglobin are more likely to walk slowly and have weaker grip strength. Data from the large REGARDS cohort found that low hemoglobin was associated with recurrent falls, and that the mechanism appeared to work through its combined effects on physical performance, cognition, and muscle function rather than any single pathway.25PubMed Central. Low Hemoglobin and Recurrent Falls in U.S. Men and Women: Prospective findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort
Anemia and Dementia Risk
The brain is exquisitely sensitive to oxygen supply, so it is not surprising that hemoglobin levels and cognitive health are connected. But the shape of that connection is more nuanced than “lower is worse.” A large Rotterdam Study analysis found a U-shaped relationship: both low and high hemoglobin were associated with increased dementia risk. People with anemia had about a 34 percent higher risk of all-cause dementia and a 41 percent higher risk of Alzheimer disease specifically. Brain imaging in participants without dementia showed that low hemoglobin correlated with changes in white-matter integrity and blood flow patterns.26PubMed Central. Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI
A more recent study tracking over 2,000 older adults for up to 16 years found that the rate of new dementia cases in people with anemia was more than twice the rate in those with normal hemoglobin, and that anemia was associated with roughly a 66 percent higher hazard of developing dementia even after adjusting for other chronic diseases, body weight, and inflammation.27JAMA Network Open. Anemia and Blood Biomarkers of Alzheimer Disease in Dementia Development Whether correcting anemia can reduce dementia risk remains an open question, but these numbers make a strong case that hemoglobin should be part of the conversation around cognitive health in aging.
Anemia and the Heart
Low hemoglobin forces the heart to work harder to deliver the same amount of oxygen. Over time, chronic anemia promotes structural changes in the heart, including thickening and enlargement of the left ventricle. Animal research has shown that iron-deficiency anemia triggers ventricular dilation and hypertrophy even when the heart’s pumping function initially remains preserved.28PubMed. Adaptive response of the heart to long-term anemia induced by iron deficiency In people who already have heart failure, anemia worsens outcomes through multiple intersecting pathways: inflammation, fluid overload, and direct damage to heart muscle cells. Markers of cardiac remodeling, heart-muscle stretch, and cell death all correlate with the presence of anemia in heart failure patients.29PubMed. Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes For older adults with existing cardiovascular disease, maintaining adequate hemoglobin is not optional.
Treating Anemia in Older Adults
Treatment depends entirely on the cause, which is why the diagnostic workup matters so much. Iron replacement sounds simple, but oral iron supplements are notorious for side effects in older adults, including constipation, cramping, and nausea, which can be severe enough that patients stop taking them.30Blood. How I treat anemia in older adults – Section: Management of IDA Intravenous iron bypasses the gut entirely and has become a more common approach when oral supplementation fails or when iron needs to be replaced quickly. B12 injections or high-dose oral B12 correct deficiency from malabsorption. Thyroid hormone replacement addresses hypothyroidism-driven anemia. For inflammation-mediated anemia, the strategy focuses on controlling the underlying disease rather than supplementing a nutrient that is technically present but inaccessible.
What makes anemia management in older adults genuinely hard is the frequency of multiple simultaneous causes. A person can have mild kidney impairment, low-grade inflammation from arthritis, suppressed erythropoietin from an ACE inhibitor, and marginal B12 absorption from atrophic gastritis, all at once. Each factor alone might produce only a slight dip in hemoglobin, but stacked together they push a person into clinically meaningful anemia. Unpicking and addressing each layer is the work of geriatric medicine, and it resists simple fixes.